This application refers to continuing studies on the HLA-linked genetic component of the susceptibility to Type 1 diabetes (T1D) and on the pathogenetic mechanisms that result in decompensation in those at genetic risk. Previous data indicate that the DR alleles positively associated with T1D (DR3 and DR4) and those negatively associated (DR2 and DR5) are parts of haplotypes that are different in """"""""affected"""""""" and """"""""unaffected"""""""" conditions (""""""""affected"""""""" designates those haplotypes present in the patient and """"""""unaffected"""""""" refers to the other HLA haplotypes of the pedigree). We propose to establish whether these different haplotypes involve structurally different though serologically identical DR and DQ genes. Southern blotting of genomic DNA restriction fragments (RF) with cDNA probes corresponding to the alpha and beta chain genes of DR and DQ will be performed on all members of selected pedigrees and the RF patterns associated with the different haplotypes will be thereby identified. The patterns of """"""""affected"""""""" and """"""""unaffected"""""""" haplotypes will be compared to determine whether systematic differences exist. Additional prospective studies will be conducted to determine the metabolic and immunological changes that precede the decompensation of individuals at risk among the relatives of T1D patients and also among Congenital Rubella (CR) and Gestational Diabetic (GD) patients. The latter groups of patients exhibit HLA associations identical to those of classical T1D. Islet cell-specific Cellular immune functions will be investigated as well as the presence and concentrations of islet-cell specific antibodies. These data will improve our ability to estimate the true risks of decompensation for individual carriers of the different HLA alleles among relatives of probands and to study whether the same genetic variants present in """"""""affected"""""""" T1D haplotypes are found in CR patients with diabetes and in decompensated former GD women. Further studies of polymorphic RF linked to the Gm genes will be performed in multiplex sibships in order to determine whether these genes influence the liability to T1D.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Method to Extend Research in Time (MERIT) Award (R37)
Project #
5R37DK019631-12
Application #
3483303
Study Section
Immunobiology Study Section (IMB)
Project Start
1977-01-01
Project End
1990-12-31
Budget Start
1988-01-01
Budget End
1988-12-31
Support Year
12
Fiscal Year
1988
Total Cost
Indirect Cost
Name
New York Blood Center
Department
Type
DUNS #
City
New York
State
NY
Country
United States
Zip Code
10065
McEvoy, R C; Thomas, N M; Greig, F et al. (1996) Anti-islet autoantibodies detected by monoclonal antibody 1A2: further studies suggesting a role in the pathogenesis of IDDM. Diabetologia 39:1365-71
Rubinstein, P; Walker, M; Mollen, N et al. (1990) No excess of DR*3/4 in Ashkenazi Jewish or Hispanic IDDM patients. Diabetes 39:1138-43
Thomas, N M; Ginsberg-Fellner, F; McEvoy, R C (1990) Strong association between diabetes and displacement of mouse anti-rat insulinoma cell monoclonal antibody by human serum in vitro. Diabetes 39:1203-11
Ginsberg-Fellner, F (1990) Insulin-dependent diabetes mellitus. Pediatr Rev 11:239-47
Rodriguez de Cordoba, S; Marshall, P; Rubinstein, P (1989) Molecular characterization by high resolution isoelectric focusing of the products encoded by the class II region loci of the MHC in humans. II. DP alpha and DP beta gene variants. J Immunol 142:836-41
Carrier, C; Mollen, N; Ginsberg-Fellner, F et al. (1989) DQA1 restriction fragment length polymorphisms and insulin-dependent diabetes mellitus: a BglII fragment labels a subset of B8,DR3 haplotypes uniquely associated with insulin-dependent diabetes mellitus. Hum Immunol 26:344-52
Rodriguez de Cordoba, S; Marshall, P; Rubinstein, P (1989) Twenty-six DR beta and 16 DQ beta chain IEF variants and their associated HLA-DR, HLA-DQ, and HLA-Dw specificities. Immunogenetics 29:49-53
Carrier, C M; Mollen, N; Rothman, W C et al. (1989) Definition of IDDM-associated HLA DQ and DX RFLPs by segregation analysis of multiplex sibships. Hum Immunol 24:51-63
Rey-Campos, J; Rubinstein, P; Rodriguez de Cordoba, S (1988) A physical map of the human regulator of complement activation gene cluster linking the complement genes CR1, CR2, DAF, and C4BP. J Exp Med 167:664-9
McEvoy, R C; Fedun, B; Cooper, L Z et al. (1988) Children at high risk of diabetes mellitus: New York studies of families with diabetes and of children with congenital rubella syndrome. Adv Exp Med Biol 246:221-7

Showing the most recent 10 out of 12 publications